Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
about
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo.Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs.The role of vildagliptin in the management of type 2 diabetes mellitus.Orlistat in the prevention of diabetes in the obese patientMetabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins.Weight Regain After Gastric Bypass: Influence of Gut Hormones.Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance.
P2860
Q27647464-8392018F-FD92-41AE-B8A1-07BD91D1D0CDQ33194892-645F94F6-812D-40C1-BB0A-4FC5701CAE3DQ33225025-1C667E35-40C1-4B6C-A998-1B1C20806BB7Q33608023-C4FFDF9B-2E45-4057-A901-55A70CD75E93Q36040879-F7E9F630-91B8-4AF8-9CFB-84A66BB91553Q36800624-05FBB1C5-133A-4A17-B64E-340F72633F1CQ36812759-144A38E2-E4CF-442B-AC77-422E75D5B1E9Q38346050-236BFA72-58EA-4416-85AB-CE3A041B3039Q38830096-72058710-8957-4451-9565-595398DCD4F5Q42078124-175162F8-3712-423B-BDC8-C1F522772845Q47355415-84A4A0A0-28B9-467B-AE63-DAB5722AED53Q51307232-E3992AB1-53A2-480F-BEA3-A3EFE068E170
P2860
Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@ast
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@en
type
label
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@ast
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@en
prefLabel
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@ast
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@en
P1433
P1476
Glucagon-like peptide 1 and ga ...... s in type 2 diabetes mellitus.
@en
P2093
Juris J Meier
Michael A Nauck
P304
P356
10.2165/00063030-200317020-00002
P577
2003-01-01T00:00:00Z
P6179
1052345597